Literature DB >> 23146029

Can telomere shortening in human peripheral blood leukocytes serve as a disease biomarker of Friedreich's ataxia?

Imma Castaldo1, Paola Vergara, Michele Pinelli, Alessandro Filla, Giuseppe De Michele, Sergio Cocozza, Antonella Monticelli.   

Abstract

Enhanced oxidative stress and inflammation contribute to telomere erosion. Friedreich's ataxia is a neurodegenerative disorder caused by a reduction in frataxin expression that results in mitochondrial dysfunction and oxidative damage. Furthermore, frataxin deficiency induces a strong activation of inflammatory genes and neuronal death. We investigated telomere length (TL) in peripheral blood leukocytes of 37 patients with Friedreich's ataxia and 36 controls. We noted a significant telomere shortening in patients with Friedreich's ataxia compared to healthy controls (p=0.03). We also found a correlation between TL and disease duration (p=0.001). Our observations lead to the hypothesis that the TL of human peripheral blood leukocytes may serve as a biomarker of Friedreich's ataxia that could be used as an outcome measure in clinical trials.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23146029      PMCID: PMC3584504          DOI: 10.1089/ars.2012.5009

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  9 in total

1.  Telomere measurement by quantitative PCR.

Authors:  Richard M Cawthon
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

2.  Oxidative stress shortens telomeres.

Authors:  Thomas von Zglinicki
Journal:  Trends Biochem Sci       Date:  2002-07       Impact factor: 13.807

3.  Shorter telomeres in patients with cerebral autosomal dominant arteriopathy and leukoencephalopathy (CADASIL).

Authors:  Michele Ragno; Luigi Pianese; Michele Pinelli; Serena Silvestri; Gabriella Cacchiò; Fabio Di Marzio; Maria Scarcella; Francesco Coretti; Fabiana Altamura; Antonella Monticelli; Imma Castaldo
Journal:  Neurogenetics       Date:  2011-09-01       Impact factor: 2.660

Review 4.  Friedreich's ataxia: past, present and future.

Authors:  Daniele Marmolino
Journal:  Brain Res Rev       Date:  2011-04-17

Review 5.  The telomere syndromes.

Authors:  Mary Armanios; Elizabeth H Blackburn
Journal:  Nat Rev Genet       Date:  2012-09-11       Impact factor: 53.242

Review 6.  Diagnosis and treatment of Friedreich ataxia: a European perspective.

Authors:  Jörg B Schulz; Sylvia Boesch; Katrin Bürk; Alexandra Dürr; Paola Giunti; Caterina Mariotti; Francoise Pousset; Ludger Schöls; Pierre Vankan; Massimo Pandolfo
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

7.  Analysis of telomeres in peripheral blood cells from patients with bone marrow failure.

Authors:  Elisa Pavesi; Federica Avondo; Anna Aspesi; Paola Quarello; Alberto Rocci; Chiara Vimercati; Simona Pigullo; Carlo Dufour; Ugo Ramenghi; Irma Dianzani
Journal:  Pediatr Blood Cancer       Date:  2009-09       Impact factor: 3.167

8.  Frataxin deficiency induces Schwann cell inflammation and death.

Authors:  Chunye Lu; Robert Schoenfeld; Yuxi Shan; Hsing-Jo Tsai; Bruce Hammock; Gino Cortopassi
Journal:  Biochim Biophys Acta       Date:  2009-08-10

Review 9.  Healthy aging and disease: role for telomere biology?

Authors:  Haidong Zhu; Matthew Belcher; Pim van der Harst
Journal:  Clin Sci (Lond)       Date:  2011-05       Impact factor: 6.124

  9 in total
  2 in total

1.  Identification of telomere dysfunction in Friedreich ataxia.

Authors:  Sara Anjomani Virmouni; Sahar Al-Mahdawi; Chiranjeevi Sandi; Hemad Yasaei; Paola Giunti; Predrag Slijepcevic; Mark A Pook
Journal:  Mol Neurodegener       Date:  2015-06-10       Impact factor: 14.195

2.  Deep sequencing of mitochondrial genomes reveals increased mutation load in Friedreich's ataxia.

Authors:  Angela D Bhalla; Alireza Khodadadi-Jamayran; Yanjie Li; David R Lynch; Marek Napierala
Journal:  Ann Clin Transl Neurol       Date:  2016-06-14       Impact factor: 4.511

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.